Sunshine Biopharma Inc.
SBFM· Nasdaq
SBFMSunshine Biopharma Inc.
Filed Aug 17, 2018 · 10-Q · 48 days after period end · 0001654954-18-009279
| Metric | Q2 2018 | Q2 2017 | Q2 2016 | Q2 2015 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $1.71K |
| Net Income | -$644.31K | -$485.44K | -$481.31K | -$517.51K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 17, 2018 · 48 d after period end
